HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasodha Sivasothy Selected Research

malabaricone C

3/2022Giganteone A and malabaricone C as potential pharmacotherapy for diabetes mellitus.
8/2019Malabaricone C as Natural Sphingomyelin Synthase Inhibitor against Diet-Induced Obesity and Its Lipid Metabolism in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasodha Sivasothy Research Topics

Disease

2Infections
04/2016 - 02/2016
2Malaria
04/2016 - 02/2016
1Diabetes Mellitus
03/2022
1Obesity
08/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2019
1Weight Gain
08/2019
1Breast Neoplasms (Breast Cancer)
01/2018

Drug/Important Bio-Agent (IBA)

2malabaricone CIBA
03/2022 - 08/2019
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2022
1giganteone AIBA
03/2022
1phosphatidylcholine-ceramide phosphocholine transferaseIBA
08/2019
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2019
1Glucose (Dextrose)FDA LinkGeneric
08/2019
1Therapeutic UsesIBA
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018
1Free RadicalsIBA
04/2016
1AlkaloidsIBA
02/2016
1AntioxidantsIBA
02/2016

Therapy/Procedure

1Glycemic Control
03/2022
1Drug Therapy (Chemotherapy)
03/2022
1Oral Administration
08/2019